News
FEED
0.203
-2.12%
-0.004
Weekly Report: what happened at FEED last week (1026-1030)?
Weekly Report · 1d ago
ENvue Medical commences U.S production of UroShield
TipRanks · 5d ago
ENvue Medical Commences U.S. Production of UroShield(R) and Begins Fulfilling UK Distributor Orders
Barchart · 5d ago
ENvue Medical CEO says ‘optimistic’ about opportunities ahead of company
TipRanks · 10/26 11:41
Weekly Report: what happened at FEED last week (1019-1023)?
Weekly Report · 10/26 09:48
ENvue Medical Issues Letter to Shareholders
Barchart · 10/26 06:30
Weekly Report: what happened at FEED last week (1012-1016)?
Weekly Report · 10/19 09:48
ENvue Medical Secures New Financing and Recapitalization Terms
TipRanks · 10/14 21:47
Weekly Report: what happened at FEED last week (1005-1009)?
Weekly Report · 10/12 09:51
Weekly Report: what happened at FEED last week (0928-1002)?
Weekly Report · 10/05 09:50
Weekly Report: what happened at FEED last week (0921-0925)?
Weekly Report · 09/28 09:47
Weekly Report: what happened at FEED last week (0914-0918)?
Weekly Report · 09/21 09:48
Envue Medical (FEED) Shares Fall 23% After Hours: Here's What Is Going On
Benzinga · 09/16 06:56
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/15 21:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 09/15 17:06
ENvue Medical denied request for continued listing on Nasdaq
TipRanks · 09/15 16:50
Weekly Report: what happened at FEED last week (0907-0911)?
Weekly Report · 09/14 09:51
ENvue Medical resumes U.S. commercial shipments of PainShield
TipRanks · 09/09 13:05
ENvue Medical Restarts Commercial Shipment Of PainShield Produced In U.S.
Benzinga · 09/09 12:32
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 09/09 12:06
More
Webull provides a variety of real-time FEED stock news. You can receive the latest news about ENvue Medical through multiple platforms. This information may help you make smarter investment decisions.
About FEED
ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.